Infectious Diseases

(ID004) Genomic Landscape and Clinical Impact of SARS-CoV-2 Variants: An In-depth Next Generation Sequencing (NGS) Analysis of Over 11,000 COVID-19 Clinical Specimens from a New York Academic Institution

(ID005) A DNA Test for Multiple Pathogens and Associated Antibiotic Resistance Factors Presenting in Urine, as a [5mm x 5mm] Microarray Deployed in each Well of an Automated Microplate Format.

(ID006) Use of Antigen and Molecular Testing for Coronavirus 2019 (SARS-CoV-2) among Patients with Influenza-like Illness (ILI) in the Non-inpatient Setting

(ID007) Clinical performance evaluation of a multiplex RT-PCR assay for detection of pathogens associated with sexually transmitted infections

(ID008) Expanded PCR panel testing for Identification of coinfecting Pathogens in viral respiratory tract infections.

(ID009) Sensitivity and Accuracy of a TaqMan® OpenArray™ Real-Time PCR Multiplex Research Panel for High-Throughput Detection and Identification of Gastrointestinal Pathogens

(ID010) Expanding flexible, low-cost saliva-based diagnostic and surveillance strategies: multiplex detection of respiratory pathogens beyond SARS-CoV-2

(ID011) Feasibility of unbiased metagenomic next generation sequencing (mNGS) for urinary tract pathogen detection from symptomatic patients

(ID012) Diagnostic testing preferences can help inform future public health response efforts: global insights from an international survey

(ID013) A green fecal sample prep workflow for comprehensive gut microbiome profiling & disease detection for clinical research

(ID014) Digital Microfluidic Point of Care Platform for Molecular Detection of STI Pathogens Including Drug-Resistant Gonorrhea

(ID015) Single-cell transcriptome analysis and assembly of immunoglobulins with Oxford Nanopore sequencing after MMR vaccination

(ID016) A Digital Microfluidic Sepsis Diagnostic Predicts Bacterial Infection Status with High Accuracy Using Host Response Transcriptomic Signature and Low Sample Volume

(ID017) PREVALENCE OF SEROLOGICAL AND MOLECULAR MARKERS OF HEPATITIS B VIRUS IN PATIENTS WITH SUSPECTED ACUTE HEPATITIS IN BRAZILIAN HEALTH SERVICES

(ID018) Nanofluidic PCR Assay Versus Urine Culture for Diagnosis of Urinary Tract Infection: A Comparison and Correlation of Cycle Threshold and Colony Forming Units

(ID019) Alinity m HR HPV (IUO) Assay: Designed for Evolving Cervical Cancer Screening Programs

(ID020) The Alinity m HR HPV Investigational Use Only (IUO) Assay: Designed for Management of Patients in Cervical Cancer Screening Programs

(ID021) Genomic surveillance of SARS-CoV-2 in wastewater reveals a highly divergent cryptic lineage from a single source dominating a large sewershed

(ID022) Clinical Performance Characteristics of the Alinity m HR HPV (IUO) Assay Compared to COBAS and Aptima HPV Assays

(ID023) Prevalence of high-risk HPV genotypes in a large U.S. screening and enriched population

(ID024) Detection of Middle Ear Pathogens with Multiplex PCR and Nanopore Sequencing

(ID025) Clinical Evaluation of the Seegene Anyplex™ II MTB/MDR and Cepheid Xpert® MTB/RIF PCR assays compared to standard-of-care culture in a high-risk patient population.

(ID026) igh-risk HPV genotype distribution by cervical dysplasia severity in a large U.S. clinical study High-risk HPV genotype distribution by cervical dysplasia severity in a large U.S. clinical study

(ID027) RiboMarker Platform: Accurate genome wide profiling of small RNAs from fungal pathogens to facilitate biomarker development

(ID028) Discrepancies in HIV-1 Quantification – A Comparative Study of Testing Platforms

(ID029) Correlating Culture Colony Forming Units to PCR Cycle Threshold Values in Urinary Tract Infections

(ID030) Diagnostic Accuracy Study for SARS-CoV-2 Variants Assay

(ID031) Candida auris with Echinocandins Resistance: Design and Development of a Multiplex Real-Time PCR Assay for Detection and Differentiation.

(ID032) Development of a Molecular Control for Babesia microti Blood Screening

(ID033) Role of Machine Learning in Infectious Disease Diagnosis: Insights from Bacterial Vaginosis

(ID034) An assay design pipeline for massively parallel, nano-scale syndromic panels: A case study using a viral RT-qPCR respiratory panel paired with virus-like particle (VLP) RNA quantitative controls

(ID035) How Low Can You Go? Examining Lower Repeat Thresholds For Mpox Testing

(ID036) Systematic Evaluation of the Influenza A/B Sample Stability Throughout the Sample Shipment and Storage Process for the Rapid Antigen and RT-PCR test

(ID037) After Five Years and 10,000 Specimens: A Review of the Syndromic BioFire FilmArray Meningitis / Encephalitis Panel

(ID038) Exogenous encapsulated RNA in virus-like particles (VLPs): a pathway to precise detection and enhanced analysis for real-time PCR and NGS applications

(ID039) A Cost-Consequence Analysis of Xpert® Xpress CoV-2/Flu/RSV plus for the Diagnosis of Viral Respiratory Infections from a US Health Plan Perspective

(ID040) Evaluation of Chemagic™ 360 System as an Alternative Extraction Method for the Applied BioCode FDA Cleared 17-Plex Gastrointestinal Pathogen Panel (GPP) and MDx-3000 Molecular Diagnostic System

(ID041) Performance Characterization of a Highly Multiplexed RUO STI+AMR Panel

(ID042) Performance of SeptiCyte® RAPID for Determining Probability of Sepsis in Immunocompromised Patients or Those on Immunosuppressant Therapy

(ID043) Preparation and Evaluation of MS2 Phage-Like Particles as Full Process Quality Control for Molecular Assay

(ID044) Trends of FilmArray® Respiratory Panel testing data over seven years in a pediatric medical institute

(ID045) Evaluation of Chemagic™ 360 System as an Alternative Extraction Method for the Applied BioCode FDA Respiratory Pathogen Panel (RPP) and MDx-3000 Molecular Diagnostic System

(ID046) Analysis of Extended Specimen Stability Using Six SARS-CoV-2 Molecular Assays

(ID047) A Comprehensive Respiratory Pathogen Detection Panel for Simultaneous Detection and Differentiation of SARS-CoV-2, FluA/B, and RSV

(ID048) The Impact of SARS-CoV-2 Variant Testing on Monoclonal Antibody Allocation

(ID049) Development and Evaluation of a Multiplex Real Time RT-PCR Assays on the Panther Fusion for the Detection of Enterovirus (EV)-D68, Pan-EVs and Human Parechoviruses with different EV-D68 Target Regions

(ID050) Advancing Precision Medicine of Respiratory and Urinary Infection with Precision Metagenomics

(ID051) Identification of Fungal Isolates by ITS and D1/D2 sequencing using the Phire Plant Direct PCR Kit

(ID052) Genetic Drift in Influenza-A Requires Frequent Monitoring of Primer and Probe Sequences for Viral Subtyping

(ID053) Frequency of Misidentification of Streptococcus mitis as Streptococcus pneumoniae by A Molecular Blood Culture Identification Panel

(ID054) Dual Digital PCR Coupled with High-Resolution Melt for Bacterial-Fungal Coinfections Detection

(ID055) Expansion of a low-cost, saliva-based PCR test for the detection of mpox virus

(ID056) Validation of a Multiplex Fragment Analysis-Based COVID-19 Test (CoVarScan) against Whole Genome Sequencing (WGS) to Detect SARS-CoV-2 Omicron Subvariants.

(ID057) The utility of M. tuberculosis analysis by PCR in Formalin-Fixed Paraffin-Embedded Tissue and comparative analysis with Mycobacterium sp culture

(ID058) Nanopore sequencing-based clinical metagenomics using aPoMP

(ID059) Identification of Respiratory Syncytial Virus and Human Rhinovirus in Respiratory Samples via Illumina NGS

(ID060) Detecting Periprosthetic Joint Infection by mWGS Using the Oxford Nanopore Technologies MinION

(ID061) Characterization of the enhanced enzyme for isothermal amplification – Invitrogen™ Lyo-ready Bst Polymerase

(ID062) Performance Evaluation of the Aptima® HCV Quant Dx Assay on the Panther® System in a Pediatric Hospital

(ID063) Real Time Multiplex LAMP Assay for Rapid Pathogen Detection at Point-of-Care

(ID064) Adenovirus detection, quantitation, and genotyping in immunocompromised pediatric patients

(ID065) Retrospective Review of the Yield of a Candida auris Surveillance Program at a Tertiary Cancer Center

(ID066) Characterizing Methylation of EBV DNA in Saliva Using a Novel Quantitative Method

(ID067) Revolutionizing Viral Surveillance: Leveraging LoopCap™, a MIP-Based Technology, for Comprehensive Viral Genome Coverage and Strain Variability Resilience

(ID068) Enhancing Broad-Spectrum Infection Detection in Whole Blood through Deep-Learning Assisted Multiplex Digital PCR and High-Resolution Melt Analysis

(ID069) Evaluation of Commercially Available HPV Panels with the Alinity m HR HPV Investigational Use Only (IUO) Assay

(ID070) Investigation of a COVID-19 cluster in a Hospital Unit through Complete Viral Genome Sequencing of SARS-CoV-2

(ID071) Rapid Identification of Wound Infection Etiologies Utilizing a Sequencing-Based Approach

(ID072) Assay Validation of Direct from Specimen Urine Pathogen Identification